ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

Ovarian Cancer Screening Unnecessary for Most Women, Consensus Panel Says

April 15, 1994

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

August 1, 1997

Space Station Attacked By Health Research Advocates on Earth

May 8, 1992

NCI Would Fund 152 More Grants Under President’s Budget

February 17, 1995

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992